The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 329:1853-1858 December 16, 1993 Number 25
NextNext

Lack of Immune Responsiveness to Bovine Serum Albumin in Insulin-Dependent Diabetes
Mark A. Atkinson, Mark A. Bowman, Kuo-Jang Kao, Lalita Campbell, Paula J. Dush, Shirish C. Shah, Olli Simell, and Noel K. Maclaren

 Sign up for free e-toc
 

This Article
-Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Epidemiologic studies have implicated the ingestion of cow's milk in the pathogenesis of insulin-dependent diabetes mellitus (IDDM). Moreover, in a recent study, 100 percent of patients with new-onset IDDM had antibodies against bovine serum albumin (BSA), with a majority directed against a 17-amino-acid BSA peptide (ABBOS). Cellular immune mechanisms are thought to be the principal mediators of pancreatic beta-cell destruction in IDDM.

Methods We measured the responses of peripheral-blood mononuclear cells to BSA and ABBOS or serum IgG anti-BSA antibodies (by particle-concentration fluorescence immunoassay) in 71 patients with IDDM, 55 subjects at various degrees of risk for IDDM, 36 patients with other autoimmune disorders (chronic autoimmune thyroiditis, rheumatoid arthritis, and systemic lupus erythematosus), and 48 normal subjects.

Results The responses of peripheral-blood mononuclear cells to BSA or ABBOS were positive in 2 of 24 patients with new-onset IDDM, 1 of 25 first-degree relatives of patients with IDDM who were negative for islet-cell antibodies, 2 of 30 first-degree relatives of patients with IDDM who were positive for islet-cell antibodies, 1 of 28 patients with established IDDM, and 1 of 29 normal subjects. Similarly, anti-BSA antibodies were not detected significantly more often in patients with new-onset IDDM (3 of 31, 10 percent) than in normal subjects (1 of 37, 3 percent; P = 0.32). However, many patients with autoimmune disease and subjects at increased risk for IDDM had anti-BSA antibodies (frequency, 10 to 31 percent).

Conclusions Anti-BSA antibodies may reflect a general defect in the process of immunologic tolerance associated with a predisposition to autoimmunity rather than immunity specific to beta cells. The absence of cellular immunity to BSA and ABBOS in IDDM does not support a role for this antigen in the pathogenesis of the disorder.


Source Information

From the Department of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville (M.A.A., M.A.B., K.-J.K., L.C., P.J.D., N.K.M.); the Department of Pediatrics, University of South Florida, Tampa (S.C.S.); and the Department of Pediatrics, University of Turku, Turku, Finland (O.S.).

Address reprint requests to Dr. Atkinson at the Department of Pathology, University of Florida, Box 100275 JHMHC, Gainesville, FL 32610.

Full Text of this Article


Related Letters:

Lack of Immunity to Bovine Serum Albumin in Insulin-Dependent Diabetes Mellitus
Dosch H.-M., Karjalainen J., VanderMeulen J., Atkinson M. A., Kao K.J., Maclaren N. K.
Extract | Full Text  
N Engl J Med 1994; 330:1616-1617, Jun 2, 1994. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.